Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism

  • K. Ganesh Kumar
  • , James L. Trevaskis
  • , Daniel D. Lam
  • , Gregory M. Sutton
  • , Robert A. Koza
  • , Vladimir N. Chouljenko
  • , Konstantin G. Kousoulas
  • , Pamela M. Rogers
  • , Robert A. Kesterson
  • , Marie Thearle
  • , Anthony W. Ferrante
  • , Randall L. Mynatt
  • , Thomas P. Burris
  • , Jesse Z. Dong
  • , Heather A. Halem
  • , Michael D. Culler
  • , Lora K. Heisler
  • , Jacqueline M. Stephens
  • , Andrew A. Butler*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Obesity and nutrient homeostasis are linked by mechanisms that are not fully elucidated. Here we describe a secreted protein, adropin, encoded by a gene, Energy Homeostasis Associated (Enho), expressed in liver and brain. Liver Enho expression is regulated by nutrition: lean C57BL/6J mice fed high-fat diet (HFD) exhibited a rapid increase, while fasting reduced expression compared to controls. However, liver Enho expression declines with diet-induced obesity (DIO) associated with 3 months of HFD or with genetically induced obesity, suggesting an association with metabolic disorders in the obese state. In DIO mice, transgenic overexpression or systemic adropin treatment attenuated hepatosteatosis and insulin resistance independently of effects on adiposity or food intake. Adropin regulated expression of hepatic lipogenic genes and adipose tissue peroxisome proliferator-activated receptor gamma, a major regulator of lipogenesis. Adropin may therefore be a factor governing glucose and lipid homeostasis, which protects against hepatosteatosis and hyperinsulinemia associated with obesity.

Original languageEnglish
Pages (from-to)468-481
Number of pages14
JournalCell Metabolism
Volume8
Issue number6
Early online date2 Dec 2008
DOIs
Publication statusPublished - 6 Dec 2008

Funding

This work was supported by grants from the Pennington Biomedical Research Foundation and the American Diabetes Association (1-04-JF09) and by a Sponsored Research Agreement with Biomeasure, Inc./IPSEN; Milford, MA to A.A.B. A.A.B. and R.L.M. are supported in part by CNRU Center Grant #1P30 DK072476, entitled "Nutritional Programming: Environmental and Molecular Interactions" and sponsored by the NIDDK. The UAB Transgenic Mouse Facility is supported by NIH grants P30 CA1 3148 and P30 AR48311. L.K.H. is supported by NIDDK R01DK065171 and the Wellcome Trust. H.A.H., J.Z.D., and M.D.C. are employees of Biomeasure, Inc./IPSEN; A.A.B. has been a paid consultant for Biomeasure, Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • adipose-tissue
  • insulin-resistance
  • melanocortin system
  • food-intake
  • receptor
  • glucose
  • obesity
  • liver
  • mice
  • pathogenesis

Fingerprint

Dive into the research topics of 'Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism'. Together they form a unique fingerprint.

Cite this